Victor Santana-Duque

Madrid, MD 28670, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Adjuvant Radiotherapy After Cystectomy in Muscle-Invasive Bladder Cancer: Indications, Benefits and Remaining Challenges.

Adjuvant Radiotherapy After Cystectomy in Muscle-Invasive Bladder Cancer: Indications, Benefits and Remaining Challenges.

Journal: Archivos espanoles de urologia

Published: April 07, 2026

The role of SBRT as an ablative treatment in oligometastatic patients.

The role of SBRT as an ablative treatment in oligometastatic patients.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 24, 2026

Prognostic factors and oncological outcomes after trimodality bladder-preserving therapy for muscle-invasive bladder cancer: A multicenter real-world study.

Prognostic factors and oncological outcomes after trimodality bladder-preserving therapy for muscle-invasive bladder cancer: A multicenter real-world study.

Journal: Actas urologicas espanolas

Published: October 28, 2025

Stage III NSCLC Treatment Patterns in Spain: A Population-Based Study of the GOECP-SEOR.

Stage III NSCLC Treatment Patterns in Spain: A Population-Based Study of the GOECP-SEOR.

Journal: Cancers

Published: October 20, 2025

Management of high-risk prostate cancer in Spain: results from a national patterns of care survey.

Management of high-risk prostate cancer in Spain: results from a national patterns of care survey.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 01, 2025

GnRH Antagonists: Current Evidence and Role in Prostate Cancer.

GnRH Antagonists: Current Evidence and Role in Prostate Cancer.

Journal: Archivos espanoles de urologia

Published: August 08, 2025

Integrating Apparent Diffusion Coefficient and Prostate-Specific Antigen as Prognostic Factors of Treatment Response to Androgen Deprivation Therapy and Radiotherapy in Prostate Cancer.

Integrating Apparent Diffusion Coefficient and Prostate-Specific Antigen as Prognostic Factors of Treatment Response to Androgen Deprivation Therapy and Radiotherapy in Prostate Cancer.

Journal: Biomedicines

Published: July 14, 2025

Vascular calcifications in early-breast radiotherapy planning-CT: Opportunistic detection and cardiovascular risk assessment.

Vascular calcifications in early-breast radiotherapy planning-CT: Opportunistic detection and cardiovascular risk assessment.

Journal: Clinical and translational radiation oncology

Published: June 28, 2025

Duration of androgen deprivation therapy with salvage radiotherapy in patients with prostate cancer and biochemical recurrence after surgery: Initial recruitment data in the phase III URONCOR 06-24 trial.

Duration of androgen deprivation therapy with salvage radiotherapy in patients with prostate cancer and biochemical recurrence after surgery: Initial recruitment data in the phase III URONCOR 06-24 trial.

Journal: Actas urologicas espanolas

Published: March 11, 2025

Current role of salvage radiotherapy in oligometastatic prostate cancer at the time of recurrence.

Current role of salvage radiotherapy in oligometastatic prostate cancer at the time of recurrence.

Journal: Current opinion in urology

Published: March 04, 2025

Combining Radiation Therapy With Immune Checkpoint Inhibitors for the Management of Muscle-Invasive Bladder Cancer: A Comprehensive Systematic Review From the Y-ECI ROSC EORTC Group.

Combining Radiation Therapy With Immune Checkpoint Inhibitors for the Management of Muscle-Invasive Bladder Cancer: A Comprehensive Systematic Review From the Y-ECI ROSC EORTC Group.

Journal: Practical radiation oncology

Published: January 15, 2025

Apparent Diffusion Coefficient as an Early Predictive Factor of Local and Overall Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer.

Apparent Diffusion Coefficient as an Early Predictive Factor of Local and Overall Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer.

Journal: Cancers

Published: January 12, 2025

Showing 1-12 of 22

Last Updated: 09/26/2026